comparemela.com
Home
Live Updates
Le Meridi - Breaking News
Pages:
Le Meridi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Inhibikase Therapeutics Initiates Medical and Patient Awareness Campaign for its Phase 2 201 Trial Evaluating IkT-148009 in Parkinson s Disease
- Company to highlight the 201 trial at multiple regional seminars for physicians - - Up to 61% of clinical sites actively screening patients by close of 2Q23 - BOSTON and ATLANTA, June 21, 2023. | June 21, 2023
United states
Westin southfield
Le meridi
Alex lobo
Miltonh werner
Milton werner
Inhibikase therapeutics inc
Exchange commission
Inhibikase or company
Company contact
Sternir inc
Inhibikase therapeutics
Abelson tyrosine kinases
Abelson tyrosine kinase
Ableson tyrosine
Multiple system atrophy
vimarsana © 2020. All Rights Reserved.